As medical costs mount Japan to weigh costeffectiveness in setting drug prices

As medical costs mount, Japan to weigh cost-effectiveness in setting drug prices

13:09 EST 18 Feb 2019 | Reuters

Japanese doctor Yasushi Goto remembers prescribing the cancer drug Opdivo to an octogenarian and wondering whether taxpayers might object to helping fund treatment, which at the time cost hundreds of thousands of dollars, for patients in their twilig...

More From BioPortfolio on "As medical costs mount, Japan to weigh cost-effectiveness in setting drug prices"